Artificial Intelligence-integrated Multimodal Neural Biomarkers for Early Risk Stratification in Preclinical Alzheimer's Disease.
INTRODUCTION Alzheimer's Disease (AD) develops biologically years before overt cognitive symptoms, creating a need for preclinical risk stratification beyond single biomarker tests. METHODS This structured narrative review searched PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar for English-language litera...